MEDIA RELEASE PR37584
Oncologist at Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization
PHILADELPHIA, Dec. 15 /PRNewswire-AsiaNet/ --
Will Lead Children's Oncology Group -- Collaborative
Organization in Pediatric Cancer
Peter C. Adamson, M.D., a pediatric oncologist and leading scientist at
The Children's Hospital of Philadelphia Research Institute, has been selected
to lead the Children's Oncology Group (COG) in its efforts to find cures for
children with cancer.
An internationally recognized leader in pediatric cancer drug
development, Dr. Adamson will assume his new role with COG on Jan. 1, 2010.
He was elected by principal investigators of more than 200 COG sites. COG
unites more than 5,000 experts in childhood cancer at leading children's
hospitals, universities, and cancer centers across North America, Australia,
New Zealand, and Europe in the fight against childhood cancer.
Dr. Adamson, who came to The Children's Hospital of Philadelphia in 1999
from the National Cancer Institute, is the director of Clinical and
Translational Research and chief of the Division of Clinical Pharmacology and
Therapeutics at Children's Hospital. He also is a professor of Pediatrics and
Pharmacology at the University of Pennsylvania School of Medicine. He will
remain on the staff of Children's Hospital and on the Penn faculty while
serving as COG chair.
Emerging research shows that even the more common childhood cancers are
actually a mix of different diseases, each potentially requiring a different
specific therapy. Creating such disease-targeted therapies for children with
cancer requires a better pathway for moving from the bench to the bedside,
which Dr. Adamson will lead through expanding COG's role at Children's
Hospital and fostering new and enhanced collaborations with COG sites
throughout the world.
The Children's Hospital of Philadelphia was founded in 1855 as the
nation's first pediatric hospital. Through its long-standing commitment to
providing exceptional patient care, training new generations of pediatric
healthcare professionals and pioneering major research initiatives,
Children's Hospital has fostered many discoveries that have benefited
The Cancer Center at The Children's Hospital of Philadelphia's large
basic and clinical research programs are particularly strong in pediatric
neuro-oncology, neuroblastoma, leukemia and lymphoma, and sarcomas.
Physicians at Children's Hospital have had pioneering roles in developing
international standards for diagnosing and treating neuroblastoma, and in
developing programs for survivors of childhood cancer.
To see the full press release:
Contact: Rachel Salis-Silverman, Children's Hospital of Philadelphia,
Salis@email.chop.edu
SOURCE: The Children's Hospital of Philadelphia
CONTACT: Rachel Salis-Silverman
of The Children's Hospital of Philadelphia,
+1-267-426-6063,
Salis@email.chop.edu
NEWS 
